Condition
Lagophthalmos
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 74/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT05183282Not ApplicableCompletedPrimary
Nictavi Tarsus Patch for Managing Lagophthalmos
NCT03239418Not ApplicableTerminated
NMES to Improve Eyelid Functions in Cranial Nerve (CN) III and VII Palsy
NCT02988856Not ApplicableCompleted
Magnetic Correction of Eye Lid Paralysis
Showing all 3 trials